Overview of Refuril
What is Refuril? Definitional and Pharmacological Identity
| Property | Description |
|---|---|
| Active ingredient | Nifuroxazide |
| Form | Capsules, tablets, oral suspension |
| Pharmacological class | Intestinal antiseptic |
| Common use | Relief of acute bacterial diarrhea symptoms |
| Origin | Synthetic nitrofuran derivative |
Refuril is defined as a non-systemic anti-infective medication, classified as an intestinal antiseptic. Its core identity is derived from the single active pharmaceutical ingredient, Nifuroxazide (INN), a compound chemically identified as a synthetic nitrofuran derivative. Nifuroxazide is characterized by a targeted, non-systemic action profile, distinguishing it from conventional, widely distributed systemic antibiotics.
Composition, Origin, and Available Forms
The Nifuroxazide component, a result of chemical synthesis, makes Refuril a single-ingredient product. It is formulated for oral administration and commonly presented in high-level dosage forms, including capsules, tablets, and an oral suspension. The availability of the oral suspension form is a key factor in making the medicine suitable for pediatric use and generally accessible to patient groups who require a liquid format. In these forms, the active ingredient is combined with a pharmaceutically safe excipient base to ensure reliable delivery to the gastrointestinal tract.
General Purpose: Targeted Benefit
The overarching purpose of Refuril is to provide localized antibacterial action against the microorganisms that cause acute intestinal upset. Nifuroxazide achieves this by concentrating its effect in the gut lumen, where it interferes with the essential metabolism of susceptible bacteria, such as through the inhibition of certain bacterial dehydrogenases. This action is highly localized due to the drug’s minimal absorption from the gastrointestinal tract. The intended benefit is to help normalize the intestinal environment by reducing the pathogen load directly at the site of proliferation.
